131 results
6-K
EX-99.4
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
Pharma’s team has delivered innovative treatments to rare disease patients with high unmet medical needs. By joining forces and expertise we will be able … Global Rare Diseases
Chiesi Global Rare Diseases is a business unit of the Chiesi Group established to deliver innovative therapies and solutions
6-K
EX-99.6
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
, our mission is to transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those … -stage biopharmaceutical company focused on acquiring, developing and commercializing innovative treatments to help improve the lives of patients
6-K
EX-99.4
AMYT
Amryt Pharma Plc
1 Jul 22
Posting of Annual Report and Notice of AGM
6:00am
, CMO of Amryt Pharma, commented: “I am delighted to take on my new role as CMO and look forward to continuing our work of bringing new and innovative … on acquiring, developing and commercializing innovative treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises
6-K
EX-99.1
AMYT
Amryt Pharma Plc
19 Oct 20
Current report (foreign)
8:00am
focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises … dedicated agent for biopharma and self-medication innovative companies in CEE. The company has gathered outstanding rare disease, oncology, haematology
424B3
AMYT
Amryt Pharma Plc
31 Mar 22
Prospectus supplement
8:44am
and commercializing innovative treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a strong and growing portfolio
424B3
yn1gm
31 Jan 22
Prospectus supplement
7:35am
424B3
2zcjfvythgid
31 Jan 22
Prospectus supplement
7:33am
424B3
9ert 6c3d4wl
31 Mar 22
Prospectus supplement
8:44am
424B3
f1ci3p
23 Aug 21
Prospectus supplement
8:18am
424B3
0cc7rzr3 i7c
23 Aug 21
Prospectus supplement
8:17am
6-K
EX-99.1
z0cbthbiof37qm
4 Aug 22
Results of Annual General Meeting
7:38am
6-K
EX-99.1
a54vgahhz
1 Jun 22
Current report (foreign)
6:05am
6-K
EX-99.3
p3245ic w2
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.1
3vkj0vb ldfhtj50z1d
31 Mar 22
Results of General Meeting
8:41am
6-K
EX-99.4
m9u2p3 9s7o6
3 Nov 22
Current report (foreign)
7:44am
6-K
EX-99.1
t4px5a rrq36l5x
29 Oct 21
Current report (foreign)
6:05am
6-K
EX-99.5
f586d56qtr6hk7di
31 Jan 22
Current report (foreign)
7:32am
6-K
EX-99.6
8c5h aqyy
31 Jan 22
Current report (foreign)
7:32am
6-K
EX-99.1
e0ogdy
9 Dec 20
Amryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil
6:30am
6-K
EX-99.3
oo4j7dw1 ub46muf
29 Oct 21
Current report (foreign)
6:05am